I want to raise a really important issue about whether all hospitals are following the NICE guidelines and testing all women with early stage breast cancer for HER2. I would like to know Breast Cancer Care’s view on this.
I had an appointment with oncology at Derriford Hospital, Plymouth, in October 2007 following a mastectomy the previous month. When I inquired about my HER2 status I was told I hadn’t been tested because the hospital only tested those they considered to be high risk.
I was not given any written literature on HER2 so I could make an informed decision about whether to insist on testing. If I had known then what I know now - that 25% of breast cancers test positive for HER2 - then I certainly would have pressed for a test. But at the time I was v stressed because I had developed an infection in the site of my temporary saline expander. I simply put my trust in my oncologist that I was low risk for HER2.
In December 2007 I transferred my oncology to Treliske Hospital, Truro, where they DO follow the NICE guidelines on HER 2 testing. In early January I found out I had tested positive. This has meant that the profile of my disease and recommended treatment has changed. My 5 year survival rate has now reduced from 90% to 80% and chemotherapy, previously thought to be of little benefit, is now worth undertaking as the precursor to a course of Herceptin. Furthermore, Derriford’s decision led to a delay in my treatment, itself a risk.
Derriford Hospital appears to be gambling with women’s lives for the sake of saving A £20 test. Ultimately, I can’t help wondering if this is a way of rationing access to Herceptin.
So my advice to you all is make sure you get tested for HER2. I would like to hear of other women’s experiences of HER2 testing. How many other hospitals are ignoring the NICE guidelines?
Deborah